Viazzi, Francesca

GLP-1 receptor agonists and kidney protection

Greco, E., Russo, G., Giandalia, A., Viazzi, F., Pontremoli, R., & De Cosmo, S. (2019) · Medicina

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 173

Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised?

RATTO, E., LEONCINI, G., VIAZZI, F., VACCARO, V, PARODI, A., FALQUI, V, BEZANTE, G., TOMOLILLO, C., DEFERRARI, G., & PONTREMOLI, R. (2006) · American Journal of Hypertension

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 17

Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Heerspink, H. J. L., Jardine, M. J., Kohan, D. E., Lafayette, R., Levin, A., Liew, A., Zhang, H., Noronha, I. L., Mastroianni-Kirsztajn, G., Chow, S., et al. (2026) · The Lancet

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 12